|
DYM expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.33680000297321E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.464300E-03 |
| Normal-vs-Stage2 |
1.219570E-03 |
| Normal-vs-Stage3 |
2.24130047854487E-10 |
| Normal-vs-Stage4 |
1.15450000004458E-07 |
| Stage1-vs-Stage2 |
2.152600E-01 |
| Stage1-vs-Stage3 |
1.424280E-04 |
| Stage1-vs-Stage4 |
1.320420E-03 |
| Stage2-vs-Stage3 |
1.074350E-01 |
| Stage2-vs-Stage4 |
1.582190E-01 |
| Stage3-vs-Stage4 |
9.946000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80889999984646E-07 |
| Normal-vs-AfricanAmerican |
2.23679999966642E-07 |
| Normal-vs-Asian |
2.629500E-04 |
| Caucasian-vs-AfricanAmerican |
4.160000E-02 |
| Caucasian-vs-Asian |
2.427400E-01 |
| AfricanAmerican-vs-Asian |
6.743400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.28989998868934E-09 |
| Normal-vs-Female |
3.637900E-04 |
| Male-vs-Female |
1.130420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.420300E-03 |
| Normal-vs-Age(41-60Yrs) |
4.27370000000149E-05 |
| Normal-vs-Age(61-80Yrs) |
1.01709999977828E-07 |
| Normal-vs-Age(81-100Yrs) |
2.030300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.090400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.064000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.895200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.301000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.191600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.057200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.559000E-01 |
| Normal-vs-Grade 2 |
1.510260E-02 |
| Normal-vs-Grade 3 |
5.25389953764943E-10 |
| Normal-vs-Grade 4 |
3.13640002858051E-10 |
| Grade 1-vs-Grade 2 |
2.730000E-01 |
| Grade 1-vs-Grade 3 |
7.484100E-03 |
| Grade 1-vs-Grade 4 |
7.421400E-04 |
| Grade 2-vs-Grade 3 |
1.990760E-04 |
| Grade 2-vs-Grade 4 |
4.54650000003554E-06 |
| Grade 3-vs-Grade 4 |
3.373500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.986200E-01 |
| Normal-vs-ccB subtype |
9.20060028164471E-10 |
| ccA subtype-vs-ccB subtype |
2.88920000146575E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.04129999997949E-06 |
| Normal-vs-N1 |
3.918500E-02 |
| N0-vs-N1 |
3.836800E-01 |
|
|
